Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14.
N Engl J Med. 2022.
PMID: 35833805
Free PMC article.
Clinical Trial.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network.
Maturi RK, et al.
JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029.
JAMA. 2023.
PMID: 36749332
Free PMC article.
Item in Clipboard
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
Hutton DW, Glassman AR, Liu D, Sun JK; DRCR Retina Network.
Hutton DW, et al.
JAMA Ophthalmol. 2023 Mar 1;141(3):268-274. doi: 10.1001/jamaophthalmol.2022.6142.
JAMA Ophthalmol. 2023.
PMID: 36729431
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite